1992
DOI: 10.1097/00008483-199201000-00013
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of Restenosis by Lovastatin After Successful Coronary Angioplasty

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
38
0
2

Year Published

1993
1993
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(41 citation statements)
references
References 0 publications
1
38
0
2
Order By: Relevance
“…[27][28][29][30][31] Myocardial perfusion studies [32][33][34] and endothelial function studies 35,36) have shown clinical and functional improvements before the detection of lesional atherosclerotic regression. They also showed an improvement in vasodilatory function of vascular endothelium at the level of the coronary 30,37,38) and peripheral circulation 39) through the use of HMG-coA reductase inhibitors alone or in combination with antioxidant therapy. 29,40) Hemostatic and inflammatory processes are possibly affected by pravastatin.…”
Section: Discussionmentioning
confidence: 97%
“…[27][28][29][30][31] Myocardial perfusion studies [32][33][34] and endothelial function studies 35,36) have shown clinical and functional improvements before the detection of lesional atherosclerotic regression. They also showed an improvement in vasodilatory function of vascular endothelium at the level of the coronary 30,37,38) and peripheral circulation 39) through the use of HMG-coA reductase inhibitors alone or in combination with antioxidant therapy. 29,40) Hemostatic and inflammatory processes are possibly affected by pravastatin.…”
Section: Discussionmentioning
confidence: 97%
“…39 Lovastatin prevents restenosis in hypercholesterolemic rabbits undergoing femoral balloon angioplasty 19 and reduces restenosis rates after percutaneous transluminal coronary angioplasty in humans. 20 However, it is difficult to extrapolate from these studies any direct effect of vastatins on arterial myocyte proliferation. The former study was pursued in hypercholesterolemic animals; in the clinical study, a significant reduction of serum cholesterol was observed in the lovastatin-treated patients, even though no clear correlations between plasma cholesterol levels and restenosis rates were observed.…”
Section: Discussionmentioning
confidence: 99%
“…16 - 18 Aggressive lipid-lowering treatment with lovastatin prevented restenosis after balloon angioplasty in hypercholesterolemic rabbits 19 and humans. 20 However, no correlations between serum cholesterol and restenosis were found in percutaneous transluminal coronary angioplasty patients.…”
mentioning
confidence: 99%
“…Numerous pharmacological approaches and devices have been evaluated in an attempt to prevent restenosis. Fish oil, and trapidil (growth inhibitor) have shown promise in some trials [48,49]. Some trials that failed to demonstrate the benefit of a particular pharmacologic agent may have too few patients and uses adequate doses.…”
Section: Management Of Restenosismentioning
confidence: 99%